Cardiac disorder and Hepatic steatosis

Summary:

Hepatic steatosis is found among people with Cardiac disorder, especially for people who are male, 60+ old.

The study analyzes which people have Hepatic steatosis with Cardiac disorder. It is created by eHealthMe based on reports of 149 people who have Cardiac disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cardiac disorder?

Cardiac disorder is found to be associated with 2,042 drugs and 1,962 conditions by eHealthMe. Check the latest studies of Cardiac disorder.

What is Hepatic steatosis?

Hepatic steatosis (fatty liver disease) is found to be associated with 1,405 drugs and 1,376 conditions by eHealthMe. Check the latest studies of Hepatic steatosis.



On Aug, 06, 2026

149 people who have Cardiac Disorder and Hepatic Steatosis are studied.

Would you have Hepatic steatosis when you have Cardiac disorder?

Gender of people who have Cardiac disorder and experienced Hepatic steatosis *:

Click here to view

Age of people who have Cardiac disorder and experienced Hepatic steatosis *:

Click here to view

Common co-existing conditions for these people *:

Click here to view

Common drugs taken by these people *:

Click here to view

Common symptoms for these people *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatic steatosis?

- Check whether Hepatic steatosis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hepatic steatosis:

All the conditions that are associated with Hepatic steatosis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatic steatosis and Cardiac disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: